Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: WPP Shares Surge As It Beats Forecasts

Fri, 09th Aug 2019 10:52

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------WPP, up 6.4%. The advertising company reported its second-quarter results slightly ahead of its internal expectations, with revenue rising by 2.3% to GBP4.03 billion. The company noted that an improvement in North America and the UK was partly offset by slower growth in Asia Pacific, Latin America, Africa & the Middle East and Central & Eastern Europe. WPP said its revenue in the six months to June 30 increased by 1.6% to GBP7.61 billion from GBP7.49 billion, but pretax profit fell by 44% to GBP478.2 million from GBP846.5 million. Profit nosedived because of an exceptional loss of GBP3.0 million, largely due to restructuring costs, compared to a gain of GBP114.0 million it generated last year in relation to the sale of its investment in Globant. Looking ahead, the company reiterated its full-year guidance for revenue less pass-through costs, which is expected to fall by no more than 2%. Revenue less pass-through costs in the half-year was GBP6.15 billion, same as last year, but down 2% on a like-for-like basis. ----------Astrazeneca, up 1.4%. The pharmaceutical company said drug Tagrisso significantly improved overall survival during its phase 3 Flaura trial in non-small cell lung cancer patients. The trial involved patients with locally-advanced or metastatic lung cancer and epidermal growth factor receptor mutations. It found a "statistically-significant and clinically-meaningful improvement" in overall survival compared to previous standard-of-care treatments. Overall survival was the secondary endpoint of the study. Flaura met its primary endpoint back in July 2017 when is demonstrated an improvement in progression-free survival - time lived with no disease progression or death. Astra said Tagrisso's safety and tolerability during the study was "consistent with its established profile".----------FTSE 100 - LOSERS----------International Consolidated Airlines Group, down 1.5%. It has been a dismal week for IAG's British Airways, after a jet was forced to land as smoke poured into the cabin, an IT glitch caused the cancellation of more than 100 flights, and the BA pilots union threatened to strike over pay.----------FTSE 250 - WINNERS----------Hikma Pharmaceuticals, up 7.5%. The pharmaceutical company's profit soared in the first half of 2019, led by a strong performance from its Generics business, prompting Hikma to raise its annual expectations. Hikma posted a 60% jump in pretax profit for the six months ended June 30 to USD226 million as revenue climbed 7.3% to USD1.05 billion. Generics led the charge, with revenue up 11% to USD368 million, benefiting from in-market product demand and recent launches. Injectables also performed well, with revenue up 5.4% to USD432 million. As a result, Hikma raised its annual guidance. The second best performer was G4S, up 6.3%, as the company said it will separate its cash management division in the first half of 2020 as part of a previously announced business review. The company, which also provides security services, reported a 3.8% rise in revenue for the six months to June-end, but profit fell on disposals, onerous contracts, exchange rate movements, restructuring and separation costs, and impairment charges.----------William Hill, up 6.2%. The bookmaker posted a narrowed loss for the 26 weeks to July 2 of GBP63.5 million compared to GBP819.6 million a year earlier, as revenue rose 1.1% to GBP811.7 million from GBP802.9 million. A year ago, William Hill recorded an impairment charge of GBP882.8 million in the Retail segment following the announcement of the UK government's decision to reduce the maximum stake on fixed-odds betting terminals. William Hill said that in the first half there was a decline in Retail revenue of 12% after the implementation of GBP2 maximum stake on the gaming machines from April. In Online, William Hill reported growth of 14% during the period, primarily resulting from the acquisition of Mr Green in Sweden. There was also growth of 40% in William Hill US, driven by expansion in the country after the US Federal ban on sports betting was overturned by Supreme Court in May 2018.----------G4S, up 3.9%. The company, which provides security services, said it will separate its cash management division in the first half of 2020 as part of a previously announced business review. It also reported a 3.8% rise in revenue for the six months to June-end, but profit fell on disposals, onerous contracts, exchange rate movements, restructuring and separation costs, and impairment charges. G4S said it has received a number of unsolicited interest from third parties to acquire parts or all of the Cash Solutions businesses. For the first half, G4S recorded pretax profit of GBP108 million, down 21% on GBP137 million recorded in the year ago period. Revenue increased to GBP3.81 billion from GBP3.67 billion.----------IWG, up 1.6%. The Regus office owner said it has entered into a second strategic partnership with TKP. IWG will divest its Taiwanese operations to TKP, and the parties have agreed an exclusive master franchise agreement for the country. The service office provider said the deal follows the agreement between IWG and TKP in April for the divestment of IWG's Japanese operations to TKP and related franchise agreement in respect of the Japan market. IWG will receive gross consideration of GBP22.7 million payable in cash at completion, which is expected to occur in September. Proceeds from the divestment will be used for IWG's general corporate purposes, it said.----------OTHER MAIN MARKET AND AIM - WINNERS----------Rambler Metals, up 24%. The gold and copper producer said output rose sharply in the second quarter of 2019 due to its mining process improvement programme. Rambler said its executive management changes and the improvement programme, which began midway through 2018, were responsible for a "consistently higher" ore production rate and a higher rate of copper contained in ore in the second 2019 quarter. Ore production in the second quarter ended June 30 was 1,239 dry tonnes per day, up from 1,036 dry tonnes per day the year before - a 20% improvement. Moreover, copper contained in ore produced in the second quarter was 17.2 dry tonnes per day versus 11.7 dry tonnes per day, up 47% year-on-year.----------Amerisur Resources, up 8.6%. The oil & gas producer said multiple companies have expressed an interest in acquiring the firm during its formal sale process. Amerisur said it is engaging with potential takeover parties "in a constructive and positive manner to achieve an outcome that maximises value for all our shareholders". Shareholders were advised to take no action until the formal sales process was completed, however. Amerisur put itself up for sale in July after it reported that there was interest in the company and its assets from other companies in the industry. Since then, the company rejected a USD260 million takeover proposal from Paris-listed firm Etablissements Maurel & Prom. Maurel & Prom has a number of assets in Colombia, where Amerisur also operates. ----------Xtract Resources, up 5.7%. The metals and minerals producer said historic data overview confirmed targets for fast-track drilling at the Eureka project in the central part of the Republic of Zambia. Xtract said drilling review indicates mineralisation in Eureka pit area remains open, with particular focus to the southeast. "We are pleased by the outcome of the interim review of the extensive exploration dataset that we have acquired for Eureka. The more we examine the historic information the more we are convinced that the strong structural and geochemical trends, along with significant drill intercepts and past mining history, can be indicators of substantial copper-gold orebodies on the property," said Executive Chair Colin Bird. ----------OTHER MAIN MARKET AND AIM - LOSERS----------Pennant International, down 24%. The training solutions provider said it now expects its annual results to come in "materially" below market expectations, due to the timeline for the award of certain potential contracts moving into 2020. Pennant expects to report earnings before interest, taxes, and amortization for 2019 of GBP1.8 million. In 2018, the company reported oprtaing profit of GBP3.2 million. Pennant said its costs reduction exercise in response to the delay to the award of the major programme is ongoing, although the benefits of this exercise will have limited impact on the second half. More positively, for the first half, Pennant expects to report revenue and Ebita loss ahead of management expectations, at GBP7.3 million and GBP1.5 million, respectively. ----------On the Beach, down 18%. The package holiday company issued a profit warning due to the weakness of sterling against the euro ahead of Brexit. On the Beach said it now expects its annual performance to fall below expectations as "the increased likelihood of a no deal Brexit" has caused sterling to devalue against the euro since the start of May, accelerating in late July and "continuing into August". Despite higher second-half demand, sterling weakness has caused "a significant increase" in On the Beach prices compared to "competitors with currency hedges". On The Beach didn't provide any information in its statement Friday on the currency hedging that it does, if any. Because On the Beach's main focus is on growing the business, relative price increases have made it tough to gain market share and maintain margins at the same time. It is for this reason that 2019 performance is expected to fall below the expectations of the On the Beach board.----------

More News
5 Aug 2022 09:43

Barclays downgrades Hikma to 'equalweight' on Generics concerns

(Sharecast News) - Barclays downgraded Hikma Pharmaceuticals on Friday to 'equalweight' from 'overweight' and cut the price target to 1,750p from 2,250p as it said a lack of visibility in the generics division was a real concern.

Read more
5 Aug 2022 08:15

LONDON BRIEFING: London Stock Exchange benefits from market volatility

(Alliance News) - London Stock Exchange Group on Friday said results in the first half of 2022 improved, as this year's interim period had an extra month's worth of contribution from recent acquisition Refinitiv.

Read more
4 Aug 2022 17:05

LONDON MARKET CLOSE: Stocks shrug off BoE's UK recession warning

(Alliance News) - Stocks in London managed to end higher on Thursday despite a bleak warning from the Bank of England regarding to outlook for the UK economy as it jacked up rates by 50 basis points.

Read more
4 Aug 2022 12:09

LONDON MARKET MIDDAY: BoE hikes, expects UK recession in 4th quarter

(Alliance News) - London shares price made some gains on Thursday morning, though these fell well short of the market rise seen on mainland Europe, as traders in London showed signs of trepidation leading up to the Bank of England's interest rate decision.

Read more
4 Aug 2022 10:15

Hikma revenue flat, profits tumble in first half

(Sharecast News) - Hikma shares were tumbling on Thursday morning after the pharmaceuticals company reported flat group revenue in its first half, at $1.21bn, as it slashed its guidance on its lagging generics business.

Read more
4 Aug 2022 09:01

LONDON MARKET OPEN: FTSE 100 underperforms amid pre-BoE trepidation

(Alliance News) - The FTSE 100 underperformed European peers and traded sideways in early dealings on Thursday, with the Bank of England to take centre-stage during a week that so far has been dominated by tensions between the US and China.

Read more
4 Aug 2022 09:00

TOP NEWS: Hikma first half hit by stiff competition for Generics

(Alliance News) - Hikma Pharmaceuticals PLC shares suffered on Thursday, as it lowered annual guidance after a poor performance in its Generics business hit half-year profit.

Read more
4 Aug 2022 07:54

LONDON MARKET PRE-OPEN: Next and Serco up outlook but Hikma lowers

(Alliance News) - Stock prices in London are seen opening ever-so-slightly higher, falling short of the more convincing gains seen in Asia, with investors wary ahead of the latest Bank of England interest rate decision.

Read more
28 Jul 2022 16:06

UK earnings, trading statements calendar - next 7 days

Friday 29 July 
Allianz Technology Trust PLCHalf Year Results
Aston Martin Lagonda Global Holdings PLCHalf Year Results
AstraZeneca PLCHalf Year Results
Babcock International Group PLCFull Year Results
CMC Markets PLCTrading Statement
Croda International PLCHalf Year Results
Glencore PLCTrading Statement
Jupiter Fund Management PLCHalf Year Results
IMI PLCHalf Year Results
Impellam Group PLCHalf Year Results
Industrials REIT LtdTrading Statement
International Consolidated Airlines Group SAHalf Year Results
Intertek Group PLCHalf Year Results
Law Debenture Corp PLCHalf Year Results
Morgan Advanced Materials PLCHalf Year Results
NatWest Group PLCHalf Year Results
Premier Miton Global Renewables Trust PLCHalf Year Results
Rightmove PLCHalf Year Results
Shearwater Group PLCFull Year Results
Standard Chartered PLCHalf Year Results
Walker Crips Group PLCFull Year Results
YouGov PLCTrading Statement
Monday 1 August 
Ascential PLCHalf Year Results
Cranswick PLCQ1 Results
Dialight PLCHalf Year Results
GlobalData PLCHalf Year Results
HSBC Holdings PLCHalf Year Results
Hutchmed (China) LtdHalf Year Results
NAHL Group PLCTrading Statement
Pearson PLCHalf Year Results
Senior PLCHalf Year Results
Seraphine Group PLCFull Year Results
Spectris PLCHalf Year Results
XP Power PLCHalf Year Results
Tuesday 2 August 
BP PLCHalf Year Results
Capital & Counties Properties PLCHalf Year Results
Coats Group PLCHalf Year Results
Devro PLCHalf Year Results
Direct Line Insurance Group PLCHalf Year Results
Domino's Pizza Group PLCHalf Year Results
Fresnillo PLCHalf Year Results
Greggs PLCHalf Year Results
Keller Group PLCHalf Year Results
Man Group PLCHalf Year Results
Rotork PLCHalf Year Results
Sage Group PLCQ3 Results
Staffline Group PLCHalf Year Results
Synthomer PLCHalf Year Results
Travis Perkins PLCHalf Year Results
Virgin Money UK PLCQ3 Results
Wednesday 3 August 
Endeavour Mining PLCHalf Year Results
Ferrexpo PLCHalf Year Results
Hill & Smith Holdings PLCHalf Year Results
Hiscox LtdHalf Year Results
IP Group PLCHalf year Results
LSL Property Services PLCHalf Year Results
Taylor Wimpey PLCHalf Year Results
Thursday 4 August 
Coca-Cola Europacific Partners PLCHalf Year Results
ConvaTec Group PLCHalf Year Results
Evraz PLCHalf Year Results
Glencore PLCHalf Year Results
Gym Group PLCHalf Year Results
Hikma Pharmaceuticals PLCHalf Year Results
Meggitt PLCHalf Year Results
Mondi PLCHalf Year Results
Morgan Sindall Group PLCHalf Year Results
Next PLCTrading Statement
Pantheon International PLCFull Year Results
Revolution Beauty Group PLCFull Year Results
Rolls-Royce Holdings PLCHalf Year Results
ScS Group PLCTrading Statement
Secure Trust Bank PLCHalf Year Results
Serco Group PLCHalf Year Results
Spirent Communications PLCHalf Year Results
Tritax Big Box REIT PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
18 Jul 2022 09:46

LONDON BROKER RATINGS: Trio of downgrades for Fevertree; Admiral cut

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
13 Jul 2022 10:02

LONDON BROKER RATINGS: Jefferies likes Tyman; UBS cuts Beazley

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 May 2022 10:05

LONDON BROKER RATINGS: JPMorgan cuts Hikma; Liberum likes Trustpilot

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 May 2022 08:28

LONDON BRIEFING: M&S warns on cost hit to profit but is well placed

(Alliance News) - Marks & Spencer on Wednesday reported a swing to profit for the year ended April 2, but the clothing, homewares and food retailer cautioned on profit in the year ahead, amid the war in Ukraine and investment plans.

Read more
24 May 2022 10:29

IN BRIEF: Hikma Pharmaceuticals Chief Executive Siggi Olafsson resigns

Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Says Siggi Olafsson has resigned as chief executive officer and from the board to "pursue other opportunities." Adds he will remain available to the company until he resigns on June 24. Olafsson was appointed as CEO in 2018. Before he joined Hikma, he was president of peer firm Actavis Generics until 2014 from 2012.

Read more
24 May 2022 08:24

LONDON BRIEFING: Barclays launches delayed GBP1 billion share buyback

(Alliance News) - Barclays said it will kick off a GBP1.00 billion share buyback programme on Tuesday. The programme, initially announced in February, had been delayed in March after the bank admitted it sold more financial products to investors than it was allowed to.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.